Antitrust Jury Verdicts Settlements

In a major antitrust battle over cardiac catheter markets, Innovative Health LLC sued Biosense Webster, Inc. for monopolization, attempted monopolization, and unlawful tying under the Sherman Act and California’s Cartwright Act. The case centered on Biosense’s CARTO 3 cardiac mapping system and its high-density mapping and ultrasound catheters. Innovative alleged Biosense tied clinical support to catheter purchases, blocked reprocessed competitors, and restricted hospital choices. On May 16, 2025, a California jury sided with Innovative on four counts, awarding $147,406,481 in damages, which are trebled by law to $442,219,443. The verdict underscores strict enforcement of antitrust rules in medical device markets and highlights the risks of exclusionary practices.

A Delaware jury delivered a mixed verdict in Regeneron’s antitrust suit against Amgen over PCSK9 cholesterol drugs Praluent and Repatha. Regeneron accused Amgen of using exclusionary bundling tactics to block Praluent’s market access and preserve Repatha’s monopoly. The jury found Amgen liable on some claims but awarded little or no damages, siding with Amgen on key issues and significantly limiting Regeneron’s recovery. The decision underscores the challenges of proving financial harm in complex pharmaceutical antitrust disputes.

Plaintiffs accused SmileDirectClub and Align Technology of anti-competitive practices that inflated aligner prices and limited consumer choice. The lawsuit claimed unlawful monopolization, market allocation, and unfair trade practices. Align denied wrongdoing but agreed to a $31.75 million nationwide settlement, providing compensation to U.S. consumers who purchased SmileDirectClub aligners between October 2017 and August 2022. The agreement released claims against Align while excluding SmileDirectClub.

On June 27, 2024, the Los Angeles jury found the NFL liable for $4,610,331,671.74 in damages to the residential class (home subscribers) and $96,928,272.90 in damages to the commercial class (business subscribers) in the present antitrust lawsuit. The present class action was initiated on December 10, 2015, to fight the antitrust practice and monopoly of the NFL over football telecasts in the United States. Hon. Philip S. Gutierrez presided over this case. [Case number: 2:15ml2668] Plaintiffs Ninth Inning Inc. operating as The Mucky Duck, 1465 Third Avenue Restaurant Corp. doing business as Gael Pub, along with Robert Gary Lippincott, Jr., and Jonathan Frantz, through their legal representatives, asserted that the 32 professional football teams of the National Football League (NFL), in collaboration with DirecTV and others, conspired to eliminate competition in the broadcasting and sale of live professional football games, s

Court: Delaware State, Wilmington Division, District Court Case Number: 1:15cv108 Filed: January 29, 2015 Judges: Richard G. Andrews | Sherry R. Fallon Case Type: Antitrust (410) Cause: Antitrust Litigation Plaintiff(s): International Construction Products LLC Counsel for Plaintiff: Daniel Alan Mason | Matthew D. Stachel | John W. Shaw | Nathan Roger Hoeschen | Amy J. Mauser | Wells Harrell | James P. Denvir | Jonathan Shaw | William Bloom | Christopher G. Renner | David M. Fry

Court: United States District Court, Colorado, Denver Case number: 1:19cv872 Filed: March 22, 2019 Judge: Magistrate Judge Michael E. Hegarty Case type: Antitrust (410) Plaintiff: Chase Manufacturing, Inc. d/b/a Thermal Pipe Shields Counsel for Plaintiff: Geoffrey N. Blue | Alexandra H. Shear | Eric R. Olson | Isabel Juliana Broer | James F. Lerner | Jarod Michael Bona | Kenzo Sunao Kawanabe | Luke Hasskamp | Sean C. Grimsley Expert Witnesses for Plantiff: Frederick Warren-Boulton Defendant: Johns Manville Corporation | Industrial Insulation Group, LLC (later terminated on August 08, 2019) Counsel for De